PersonFounderExecutive
Matt Wilsey
Matt Wilsey is a Silicon Valley entrepreneur turned biotech founder and CEO of Grace Science, a company building gene therapy and small-molecule programs for NGLY1 deficiency, an ultra-rare genetic condition that his daughter Grace was diagnosed with in 2013. A Stanford BA and MBA who started his career at the White House and the Department of Defense before co-founding Zazzle and CardSpring (acquired by Twitter), Wilsey applied a startup operator's playbook to drug discovery, funding roughly 75 scientists across 20 medical centers in five countries and partnering with Nobel laureate Carolyn Bertozzi to turn a tiny patient community into a research enterprise.
matt wilseygrace sciencengly1rare diseasebiotech foundergene therapy
